Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Surufatinib”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Testing effectiveness (Phase 2)Study completedNCT04169672
What this trial is testing

Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Hutchison Medipharma Limited 248
Testing effectiveness (Phase 2)UnknownNCT05186545
What this trial is testing

An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Female
The First Affiliated Hospital of Zhengzhou University 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476
What this trial is testing

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Looking for participantsNCT05989425
What this trial is testing

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Fudan University 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05908747
What this trial is testing

Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 29
Testing effectiveness (Phase 2)UnknownNCT05171439
What this trial is testing

Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor Samples

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 6
Not applicableNot Yet RecruitingNCT06156332
What this trial is testing

Surufatinib Combined With Serplulimab in the Treatment of Advanced Solid Tumors With Neuroendocrine Differentiation That Failed Standard Therapy

Who this might be right for
Advanced Solid Tumors With Neuroendocrine Differentiation
Shanghai Changzheng Hospital 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT05106777
What this trial is testing

Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)UnknownNCT05003037
What this trial is testing

Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Li Zhang, MD 106
Early research (Phase 1)Study completedNCT04755075
What this trial is testing

Surufatinib Hepatic Impairment Study

Who this might be right for
Hepatic Impairment
Hutchison Medipharma Limited 16
Testing effectiveness (Phase 2)Looking for participantsNCT05839275
What this trial is testing

The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma

Who this might be right for
High-Risk Localized Soft Tissue Sarcoma
Fudan University 52
Testing effectiveness (Phase 2)Looking for participantsNCT06437353
What this trial is testing

Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer

Who this might be right for
Ovarian Cancer
Anhui Provincial Cancer Hospital 74
Testing effectiveness (Phase 2)Looking for participantsNCT07357623
What this trial is testing

Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors

Who this might be right for
Pulmonary Neuroendocrine Tumor
Shanghai Chest Hospital 96
Testing effectiveness (Phase 2)UnknownNCT04929652
What this trial is testing

Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital 48
Testing effectiveness (Phase 2)UnknownNCT05595889
What this trial is testing

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerAngiogenesisChemotherapy Effect
Fujian Cancer Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06876844
What this trial is testing

Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck CancerHead and Neck Cancer Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06414915
What this trial is testing

Surufatinib Combined With Tislelizumab in Advanced Lung Cancer With Neuroendocrine Differentiation

Who this might be right for
NSCLC
National Cancer Center, China 29
Testing effectiveness (Phase 2)UnknownNCT04922658
What this trial is testing

Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 60
Post-approval studies (Phase 4)Looking for participantsNCT07272512
What this trial is testing

Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms

Who this might be right for
Neuroendocrine TumorsNeuroendocrine Neoplasms
Shanghai Zhongshan Hospital 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT05652283
What this trial is testing

Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Who this might be right for
Ovarian Cancer
Bai-Rong Xia 37
Load More Results